Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

A fixed combination of perindopril and indapamide reduces the risk of vascular outcomes in type 2 diabetes mellitus

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 254–255 (2008)Cite this article

boxed-textPatel A et al. (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370: 829–840

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041

  2. Chobanian AV et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560–2571

    Google Scholar 

  3. Lewington S et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903–1913

    Google Scholar 

  4. Giles TD (2006) Blood pressure goals for hypertension guidelines: what is wrong with “optimal”. J Clin Hypertens 8: 835–839

    Google Scholar 

  5. Adler AI et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412–419

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Section of Cardiology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA tgiles4@cox.net

Authors and Affiliations

  1. TD Giles is a Professor of Medicine in the Section of Cardiology, Tulane University School of Medicine, New Orleans, LA, USA.,

    Thomas D Giles

Authors
  1. Thomas D Giles
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giles, T. A fixed combination of perindopril and indapamide reduces the risk of vascular outcomes in type 2 diabetes mellitus. Nat Rev Endocrinol 4, 254–255 (2008). https://doi.org/10.1038/ncpendmet0784

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0784

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing